Microfluidic assisted one-step fabrication of porous silicon@acetalated dextran nanocomposites for precisely controlled combination chemotherapy.

An advanced nanocomposite consisting of an encapsulated porous silicon (PSi) nanoparticle and an acid-degradable acetalated dextran (AcDX) matrix (nano-in-nano), was efficiently fabricated by a one-step microfluidic self-assembly approach. The obtained nano-in-nano PSi@AcDX composites showed improved surface smoothness, homogeneous size distribution, and considerably enhanced cytocompatibility. Furthermore, multiple drugs with different physicochemical properties have been simultaneously loaded into the nanocomposites with a ratiometric control. The release kinetics of all the payloads was predominantly controlled by the decomposition rate of the outer AcDX matrix. To facilitate the intracellular drug delivery, a nona-arginine cell-penetrating peptide (CPP) was chemically conjugated onto the surface of the nanocomposites by oxime click chemistry. Taking advantage of the significantly improved cell uptake, the proliferation of two breast cancer cell lines was markedly inhibited by the CPP-functionalized multidrug-loaded nanocomposites. Overall, this nano-in-nano PSi@polymer composite prepared by the microfluidic self-assembly approach is a universal platform for nanoparticles encapsulation and precisely controlled combination chemotherapy.

[1]  H. Santos,et al.  Inhibition of influenza A virus infection in vitro by saliphenylhalamide-loaded porous silicon nanoparticles. , 2013, ACS nano.

[2]  B. Cohen,et al.  Rapid cytosolic delivery of luminescent nanocrystals in live cells with endosome-disrupting polymer colloids. , 2010, Nano letters.

[3]  D. Weitz,et al.  Microfluidic assembly of multistage porous silicon-lipid vesicles for controlled drug release. , 2014, Lab on a chip.

[4]  J. Baek,et al.  Nanocomposites Derived from Polymers and Inorganic Nanoparticles , 2010, Materials.

[5]  R. K. Shah,et al.  Monodisperse Thermoresponsive Microgels with Tunable Volume‐Phase Transition Kinetics , 2007 .

[6]  Hélder A Santos,et al.  Copper-free azide-alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake. , 2014, Biomaterials.

[7]  H. Santos,et al.  Amine modification of thermally carbonized porous silicon with silane coupling chemistry. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[8]  Joel A. Cohen,et al.  Mannosylated dextran nanoparticles: a pH-sensitive system engineered for immunomodulation through mannose targeting. , 2011, Bioconjugate chemistry.

[9]  Guojie Wang,et al.  Drug delivery systems for differential release in combination therapy , 2011, Expert opinion on drug delivery.

[10]  Robert Langer,et al.  Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices. , 2012, Nano letters.

[11]  Robert Langer,et al.  Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy , 2010, Proceedings of the National Academy of Sciences.

[12]  Kyle E Broaders,et al.  Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications. , 2008, Journal of the American Chemical Society.

[13]  Jarno Salonen,et al.  Nanostructured Porous Silicon‐Solid Lipid Nanocomposite: Towards Enhanced Cytocompatibility and Stability, Reduced Cellular Association, and Prolonged Drug Release , 2013 .

[14]  Vesa-Pekka Lehto,et al.  Microfluidic assembly of monodisperse multistage pH-responsive polymer/porous silicon composites for precisely controlled multi-drug delivery. , 2014, Small.

[15]  Wyatt N Vreeland,et al.  Microfluidic mixing and the formation of nanoscale lipid vesicles. , 2010, ACS nano.

[16]  G. W. Pratt,et al.  Modular ‘Click‐in‐Emulsion’ Bone‐Targeted Nanogels , 2012, Advanced materials.

[17]  H. Gu,et al.  Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells , 2012, International journal of nanomedicine.

[18]  C Jeffrey Brinker,et al.  Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery. , 2009, Journal of the American Chemical Society.

[19]  H. Santos,et al.  Functional hydrophobin-coating of thermally hydrocarbonized porous silicon microparticles. , 2011, Biomaterials.

[20]  L. Canham,et al.  Derivatized Mesoporous Silicon with Dramatically Improved Stability in Simulated Human Blood Plasma , 1999 .

[21]  Peter York,et al.  Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. , 2009, International journal of pharmaceutics.

[22]  Joel A. Cohen,et al.  Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy , 2009, Proceedings of the National Academy of Sciences.

[23]  Michael J Sailor,et al.  Biodegradable luminescent porous silicon nanoparticles for in vivo applications. , 2009, Nature materials.

[24]  Jarno Salonen,et al.  Fabrication of a Multifunctional Nano‐in‐micro Drug Delivery Platform by Microfluidic Templated Encapsulation of Porous Silicon in Polymer Matrix , 2014, Advanced materials.

[25]  Erkki Ruoslahti,et al.  Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs , 2010, Science.

[26]  H. Santos,et al.  Multifunctional porous silicon for therapeutic drug delivery and imaging. , 2011, Current drug discovery technologies.

[27]  Lisa Brannon-Peppas,et al.  Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.

[28]  G. Whitesides The origins and the future of microfluidics , 2006, Nature.

[29]  Nicolas H Voelcker,et al.  The biocompatibility of porous silicon in tissues of the eye. , 2009, Biomaterials.

[30]  Samuel Zalipsky,et al.  Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. , 2004, Advanced drug delivery reviews.

[31]  Hongzhe Sun,et al.  Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway , 2002, Pharmacological Reviews.

[32]  Vesa-Pekka Lehto,et al.  Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats. , 2010, ACS nano.

[33]  Patrick V. Almeida,et al.  The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility. , 2013, Biomaterials.

[34]  Joel A. Cohen,et al.  Chemoselective ligation in the functionalization of polysaccharide-based particles. , 2009, Journal of the American Chemical Society.

[35]  F. Kratz,et al.  Finding the optimal balance: challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Lena Mäler Solution NMR studies of cell-penetrating peptides in model membrane systems. , 2013, Advanced drug delivery reviews.

[37]  Robert Langer,et al.  Microfluidic platform for controlled synthesis of polymeric nanoparticles. , 2008, Nano letters.

[38]  Robert K Prud'homme,et al.  Mechanism for rapid self-assembly of block copolymer nanoparticles. , 2003, Physical review letters.

[39]  Robert Langer,et al.  Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy. , 2013, ACS nano.

[40]  Niklas Sandler,et al.  Microfluidic templated mesoporous silicon-solid lipid microcomposites for sustained drug delivery. , 2013, ACS applied materials & interfaces.

[41]  Hélder A Santos,et al.  Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy. , 2013, Biomaterials.

[42]  Robert Langer,et al.  Microfluidic technologies for accelerating the clinical translation of nanoparticles. , 2012, Nature nanotechnology.

[43]  Ho Sup Yoon,et al.  Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer , 2006, Nature materials.

[44]  H. Santos,et al.  Drug permeation across intestinal epithelial cells using porous silicon nanoparticles. , 2011, Biomaterials.

[45]  Joel A. Cohen,et al.  Acetal‐Modified Dextran Microparticles with Controlled Degradation Kinetics and Surface Functionality for Gene Delivery in Phagocytic and Non‐Phagocytic Cells , 2010, Advanced materials.

[46]  Vesa-Pekka Lehto,et al.  Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[47]  Robert Langer,et al.  Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles. , 2012, Nanomedicine.

[48]  Yifan Jiang,et al.  Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. , 2013, Advanced drug delivery reviews.

[49]  A. Palmer,et al.  Site-selective glycosylation of hemoglobin with variable molecular weight oligosaccharides: potential alternative to PEGylation. , 2012, Journal of the American Chemical Society.

[50]  H. Santos,et al.  Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications. , 2014, Nanomedicine.

[51]  Robert Langer,et al.  Single step reconstitution of multifunctional high-density lipoprotein-derived nanomaterials using microfluidics. , 2013, ACS nano.

[52]  M. Morris,et al.  Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. , 2008, Advanced drug delivery reviews.

[53]  P. Musto,et al.  Compatibilizing polyimide/silica hybrids by alkoxisilane-terminated oligoimides: Morphology–Properties relationships , 2011 .